Combivent Respimat (
generic name: ipratropium bromide and albuterol) is a bronchodilator that helps dilate the airways for people with chronic obstructive pulmonary disease (COPD).
Ipratropium bromide and albuterol combined are indicated for use in patients COPD who are already being treated with a regular aerosol bronchodilator but continue to have evidence of bronchospasm and require a second bronchodilator. Studies have shown that ipratropium bromide and albuterol work together to open the airways more than either can do on its own.
NOTE: Combivent Respimat is not intended for treating asthma or relieving acute bronchospasm and doesn’t replace a rescue inhaler.
Dosage
Follow the prescribing doctor’s instructions and the guide printed on the Product Information leaflet that comes with each Combivent Respimat pack. The usual dose is for daily use, up to four inhalations daily, and not exceeding six inhalations in 24 hours.
Storage
Keep the medicine stored at temperatures below 77°F (25°C). Read our blog on
handling medicine safely.
FAQ
Is there a cure for COPD?
COPD has no cure. The damage that was done to the lung tissue cannot be reversed. The purpose of Combivent Respimat medication is to reduce the frequency and intensity of attacks caused by a shortage of breath.
Is COPD life-threatening?
The effects of COPD can differ from person to person. Even with careful treatment, COPD may get worse and can pose life-threatening risks. The condition is irreversible, but proper treatment can prevent it from interfering with regular activity.
Is there a difference between COPD and asthma?
Chronic Obstructive Pulmonary Disease (COPD) and asthma both cause inflammation of the bronchi that can result in breathing difficulties. Asthma is more likely triggered by allergies, so the symptoms can be intermittent, and there can be long breaks between attacks. COPD usually involves more persistent symptoms that progressively worsen despite treatment.
This text is for informational purposes only. Please consult a doctor or pharmacist before using any medication.Â
Read the information leaflet that comes with the medication.
If after taking Combivent Respimat, a sudden allergic reaction (anaphylaxis) occurs, with symptoms like swelling of the face, tongue, or throat making it difficult to breathe or swallow, or there is wheezing, hives, rash, blistering, or peeling of the skin, call a doctor or 911 right away, or go to an emergency room immediately.
If the following reactions are experienced immediately after using the inhaler, stop the use of the medicine and seek medical help immediately:
- Signs of paradoxical bronchospasm, such as chest tightness, coughing, wheezing, or breathlessness.
- An attack of acute narrow-angle glaucoma, with eye pain, blurred vision, seeing halos or colored images, and red eyes.
Most people who use Combivent Respimat do not experience any adverse side effects. Doctors prescribe this medication because they assess the benefits of such treatment outweigh any likely unwanted effects.
Some of the side effects that have been reported include:
- Infection in the nose or throat
- Sore throat
- Common cold symptoms
- Cough
- Bronchitis
- Headache
- Shortness of breath
- Chest pain
- Constipation or diarrhea
- Urinary tract infection (UTI)
- Leg cramps
- Nausea
Not all side effects are listed here. If these or other unlisted symptoms persist or worsen, consult a healthcare provider or pharmacist.
The Combivent Respimat inhaler delivers ipratropium and albuterol, which work together to relax the muscles around the airways in people with chronic obstructive pulmonary disease (COPD). This allows the airways to dilate and makes it easier to breathe.